{"transactions":[{"id":1580194,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-12T22:42:52.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":100000,"derivative":{"exercise_price":44.37,"expiration_date":"2034-03-10","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-030250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024030250/ownership.xml","form_type":"4"}},{"id":1953571,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T20:47:44.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":90000,"derivative":{"exercise_price":34.18,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-018508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919123018508/doc4.xml","form_type":"4"}},{"id":2334881,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T20:24:12.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2023 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":100000,"derivative":{"exercise_price":30.01,"expiration_date":"2032-03-09","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-018467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122018467/doc4.xml","form_type":"4"}},{"id":2481717,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2021-12-07T21:13:16.000Z","date":"2021-12-06","kind":"purchase","acquired":true,"shares":4000,"price":24.4,"value":97600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-068300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919121068300/doc4.xml","form_type":"4"}},{"id":2788742,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T20:45:52.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2022 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":60000,"derivative":{"exercise_price":20.55,"expiration_date":"2031-03-11","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-21-020484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919121020484/doc4.xml","form_type":"4"}},{"id":3055505,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93147,"kind":"person","name":"Von Seggern Christopher","position":1,"cik":"0001821192","reported_name":"Von Seggern Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-17T22:38:59.000Z","date":"2020-08-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":100000,"derivative":{"exercise_price":11.27,"expiration_date":"2030-08-16","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-046974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919120046974/doc4.xml","form_type":"4"}}]}